Alcidion acquires Silverlink Software

Alcidion Group Ltd. (ASX:ALC) has acquired Silverlink PCS Software Limited.

Alcidion is transforming healthcare with smart, intuitive technology solutions that provide real-time clinical decision support. The group integrates with EMR providers and assists doctors and nurses, covering functions such as streamlining patient journeys, smart analytics to help with clinical decisions, improving patient safety and productivity amongst clinical staff through messaging applications, and data capture and interpretation.

Silverlink is one of the largest and last remaining specialist patient administration system (PAS) providers servicing the UK NHS market. It is recognized as being a flexible, cost-effective PAS that can easily integrate with other clinical systems to support a specialist modular system approach, enabling the benefits of a full electronic patient record (EPR/EMR) without single supplier lock-in.

Oaklins’ team in Australia acted as M&A corporate advisor to Alcidion Group Ltd. on the acquisition of Silverlink Software.

Servicio

M&A buy-side

Partes

“This is the second acquisition Oaklins has advised Alcidion on over the past 18 months. It has played a key role in the successful completion of both transactions. Oaklins consistently provided professional and commercial advice over the course of the transaction, which enabled us to navigate any deal issues that arose. Oaklins and its experienced team continue to show a deep understanding of the industry and remain a key strategic advisor to our company.”

Kate Quirke

Group Managing Director, Alcidion Group Limited

Contáctese con el equipo de la transacción

Scott McInnes

Director Ejecutivo

Melbourne, Australia
Oaklins Henslow

Ver perfil Ponte en contacto

Sebastian Bell

Director

Sydney, Australia
Oaklins Henslow

Ver perfil Ponte en contacto

Transacciones relacionadas

Bayer AG has entered into a takeover agreement with Cara Care

Salud | TMT

Bayer AG has entered into a takeover agreement with Cara Care

Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.

Conozca más

Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.

Salud

Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.

NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.

Conozca más

Creo Medical Group plc has completed a US$15.7 million equity fundraise

Salud

Creo Medical Group plc has completed a US$15.7 million equity fundraise

Creo Medical Group plc, the provider of pioneering endoscopic healthcare solutions to clinicians and healthcare providers across the world, has completed a US$15.7 million (£12.1 million) equity fundraise.

Conozca más